Domestic chronic disease monitoring products are growing rapidly
Release date: 2010-04-29 Textile cotton Face Mask is different from disposable face mask. It can be reuseable and promote blood circulation: Wearing a mask in the cold winter can prevent the face from being frostbited, thereby promoting blood circulation on the face Nonwoven Earloop Face Mask,Earloop Face Mask,5Ply Face Mask,Disposable Mask Template RFX+CARE Manufacturing Co.,Ltd. , https://www.rk-rfxcare.com
At present, multinational companies are paying attention to the Chinese home medical device market mainly in the field of chronic diseases and related diseases of the elderly, including blood glucose monitoring for diabetes, blood pressure measuring instruments for hypertension, and other common monitoring products that require long-term control and treatment. .
According to statistics, these fields are relatively mature in foreign markets. The investment in health care or monitoring health medical equipment has become one of the main contents of household consumption in Europe, the United States and Japan. Although domestic household medical equipment has many brands, the per capita population of patients The holding rate is still at a low level.
However, this is where its potential lies. At the 5th Biomedical and Health Engineering Summit Forum, some experts believe that China has nearly 200 million hypertensive patients and 60 million diabetic patients. If China's medical devices related to chronic diseases reach the level of developed countries, then China is annually. The scale in this field can reach several billion yuan.
The previous market data also shows that companies that have focused on home medical device products in the domestic market have entered the fast lane of development. As mentioned above, Yicheng Bioelectronics Technology Co., Ltd. has just received huge investment. According to the data, Yicheng Bioelectronics has achieved an annual growth rate of more than 50% in the past three years.
In addition, the annual growth rate of Omron Health Care has also changed from a slow or even negative growth rate before 2006 to an average annual growth rate of 30%. In 2009, its sphygmomanometer exceeded the growth rates of Japan, Europe and other countries for the first time. It accounts for about 65% of the domestic market. Wang Ying, director of the Omron Health Medical Brand Strategy Center, told this reporter that the rapid development of chronic disease medical device-related leading companies also reflects the continuous increase in the market space for household medical devices for chronic diseases and elderly diseases.
Source: Kexun